Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 551-575 of 671 matching filings.

Per page
25
Current page
23
4

OWNERSHIP DOCUMENT

Filing date
18 Jul 2012
Reporting date
16 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jul 2012
Reporting date
16 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jul 2012
Reporting date
16 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jul 2012
Reporting date
16 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-182677

REGISTRATION STATEMENT

Filing date
16 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
02 Jul 2012
Reporting date
02 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
25 Jun 2012
Reporting date
25 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
22 Jun 2012
Reporting date
22 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
18 Jun 2012
Reporting date
17 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
11 Jun 2012
Reporting date
11 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-33357

AUTO-GENERATED PAPER DOCUMENT

Filing date
30 May 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
29 May 2012
Reporting date
29 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A filing

Filing date
21 May 2012
Reporting date
17 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
10 May 2012
Reporting date
10 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33357

PRELIMINARY PROXY STATEMENT

Filing date
09 May 2012
Reporting date
17 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 May 2012
Reporting date
02 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 May 2012
Reporting date
02 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 May 2012
Reporting date
02 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 May 2012
Reporting date
02 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
02 May 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
19 Mar 2012
Reporting date
16 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-33357

10-K filing

Filing date
27 Feb 2012
Reporting date
31 Dec 2011
Next action
Verify source filing
8-K File 001-33357

8-K filing

Filing date
23 Feb 2012
Reporting date
22 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171615

424B5

Filing date
16 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .